These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14614396)

  • 1. Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs.
    Mouchawar J; Valentine Goins K; Somkin C; Puleo E; Hensley Alford S; Geiger AM; Taplin S; Gilbert J; Weinmann S; Zapka J
    Genet Med; 2003; 5(6):444-50. PubMed ID: 14614396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Genet Med; 2010 Jan; 12(1):25-31. PubMed ID: 20027114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing utilization of cancer genetic counseling services using a patient navigator model.
    Rahm AK; Sukhanova A; Ellis J; Mouchawar J
    J Genet Couns; 2007 Apr; 16(2):171-7. PubMed ID: 17277995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
    Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and attitudes of gynecologists regarding genetic counseling for hereditary breast and ovarian cancer.
    Mehnert A; Bergelt C; Koch U
    Patient Educ Couns; 2003 Feb; 49(2):183-8. PubMed ID: 12566214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.
    Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH
    Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with professional guidelines with reference to familial cancer services.
    Kyne G; Maxwell S; Brameld K; Harrison K; Goldblatt J; O'Leary P
    Aust N Z J Public Health; 2011 Jun; 35(3):226-30. PubMed ID: 21627722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
    Aitken L; Warwick L; Davis A
    Intern Med J; 2017 Mar; 47(3):311-317. PubMed ID: 28019080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares.
    Vadaparampil ST; Moreno Botero L; Fuzzell L; Garcia J; Jandorf L; Hurtado-de-Mendoza A; Campos-Galvan C; Peshkin BN; Schwartz MD; Lopez K; Ricker C; Fiallos K; Quinn GP; Graves KD
    Transl Behav Med; 2022 Jan; 12(1):. PubMed ID: 34255089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
    Moretta J; Berthet P; Bonadona V; Caron O; Cohen-Haguenauer O; Colas C; Corsini C; Cusin V; De Pauw A; Delnatte C; Dussart S; Jamain C; Longy M; Luporsi E; Maugard C; Nguyen TD; Pujol P; Vaur D; Andrieu N; Lasset C; Noguès C;
    Bull Cancer; 2018 Oct; 105(10):907-917. PubMed ID: 30268633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
    Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
    BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
    McDevitt T; Durkie M; Arnold N; Burghel GJ; Butler S; Claes KBM; Logan P; Robinson R; Sheils K; Wolstenholme N; Hanson H; Turnbull C; Hume S
    Eur J Hum Genet; 2024 May; 32(5):479-488. PubMed ID: 38443545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
    Trivers KF; Baldwin LM; Miller JW; Matthews B; Andrilla CH; Lishner DM; Goff BA
    Cancer; 2011 Dec; 117(23):5334-43. PubMed ID: 21792861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
    Arai M; Iwase T; Takazawa Y; Takeshima N
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.
    Herold N; Bredow K; Ernst C; Tüchler A; Blümcke B; Waha A; Keser E; Hauke J; Wappenschmidt B; Hahnen E; Schmutzler RK; Rhiem K
    J Genet Couns; 2024 Feb; 33(1):206-215. PubMed ID: 38351721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
    Meaney-Delman D; Bellcross CA
    Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counseling referral for ovarian cancer patients: a call to action.
    Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
    Fam Cancer; 2019 Jul; 18(3):303-309. PubMed ID: 30993488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.